Literature DB >> 26549990

Effect of radiotherapy delay in overall treatment time on local control and survival in head and neck cancer: Review of the literature.

José A González Ferreira1, Javier Jaén Olasolo2, Ignacio Azinovic3, Branislav Jeremic4.   

Abstract

Treatment delays in completing radiotherapy (RT) for many neoplasms are a major problem affecting treatment outcome, as increasingly shown in the literature. Overall treatment time (OTT) could be a critical predictor of local tumor control and/or survival. In an attempt to establish a protocol for managing delays during RT, especially for heavily overloaded units, we have extensively reviewed the available literature on head and neck cancer. We confirmed a large deleterious effect of prolonged OTT on both local control and survival of these patients.

Entities:  

Keywords:  Delays; Local control; Overall treatment time; Radiotherapy; Survival

Year:  2015        PMID: 26549990      PMCID: PMC4597087          DOI: 10.1016/j.rpor.2015.05.010

Source DB:  PubMed          Journal:  Rep Pract Oncol Radiother        ISSN: 1507-1367


  76 in total

1.  Time factors in larynx tumor radiotherapy: lag times and intertumor heterogeneity in clinical datasets from four centers.

Authors:  S A Roberts; J H Hendry
Journal:  Int J Radiat Oncol Biol Phys       Date:  1999-12-01       Impact factor: 7.038

2.  Loss of local control with prolongation in radiotherapy.

Authors:  J F Fowler; M J Lindstrom
Journal:  Int J Radiat Oncol Biol Phys       Date:  1992       Impact factor: 7.038

3.  Compromised local control due to treatment interruptions and late treatment breaks in early glottic cancer: Population-based outcomes study supporting need for intensified treatment schedules.

Authors:  Patti A Groome; Brian O'Sullivan; William J Mackillop; Lynda D Jackson; Karleen Schulze; Jonathan C Irish; Padraig R Warde; Ken M Schneider; Robert G Mackenzie; D Ian Hodson; J Alex Hammond; Sunil P P Gulavita; Libni J Eapen; Peter F Dixon; Randy J Bissett
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-01-18       Impact factor: 7.038

4.  The influence of the number of fractions and of overall treatment time on local control and late complication rate in squamous cell carcinoma of the larynx.

Authors:  B Maciejewski; G Preuss-Bayer; K R Trott
Journal:  Int J Radiat Oncol Biol Phys       Date:  1983-03       Impact factor: 7.038

5.  T2 oral tongue carcinoma treated with radiotherapy: analysis of local control and complications.

Authors:  W M Mendenhall; J T Parsons; S P Stringer; N J Cassisi; R R Million
Journal:  Radiother Oncol       Date:  1989-12       Impact factor: 6.280

6.  Similar decreases in local tumor control are calculated for treatment protraction and for interruptions in the radiotherapy of carcinoma of the larynx in four centers.

Authors:  C Robertson; A G Robertson; J H Hendry; S A Roberts; N J Slevin; W B Duncan; R H MacDougall; G R Kerr; B O'Sullivan; T J Keane
Journal:  Int J Radiat Oncol Biol Phys       Date:  1998-01-15       Impact factor: 7.038

7.  Adverse effect of treatment gaps in the outcome of radiotherapy for laryngeal cancer.

Authors:  W Duncan; R H MacDougall; G R Kerr; D Downing
Journal:  Radiother Oncol       Date:  1996-12       Impact factor: 6.280

8.  Clinical radiobiology of glottic T1 squamous cell carcinoma.

Authors:  K Skladowski; R Tarnawski; B Maciejewski; A Wygoda; K Slosarek
Journal:  Int J Radiat Oncol Biol Phys       Date:  1999-01-01       Impact factor: 7.038

9.  How fast is repopulation of tumor cells during the treatment gap?

Authors:  Rafal Tarnawski; Jack Fowler; Krzysztof Skladowski; Andrzej Swierniak; Rafal Suwiński; Boguslaw Maciejewski; Andrzej Wygoda
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-09-01       Impact factor: 7.038

10.  The effect of increasing the treatment time beyond three weeks on the control of T2 and T3 laryngeal cancer using radiotherapy.

Authors:  N J Slevin; J H Hendry; S A Roberts; A Agren-Cronqvist
Journal:  Radiother Oncol       Date:  1992-08       Impact factor: 6.280

View more
  37 in total

1.  Radiation therapy treatment facility and overall survival in the adjuvant setting for locally advanced head and neck squamous cell carcinoma.

Authors:  Nicholas C J Lee; Jacqueline R Kelly; Yi An; Henry S Park; Benjamin L Judson; Barbara A Burtness; Zain A Husain
Journal:  Cancer       Date:  2019-02-12       Impact factor: 6.860

2.  The microRNA-375 as a potentially promising biomarker to predict the prognosis of patients with head and neck or esophageal squamous cell carcinoma: a meta-analysis.

Authors:  Peng Wang; LiangLiang Xu; Lian Li; ShengSheng Ren; JianWei Tang; Ming Zhang; MingQing Xu
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-02-12       Impact factor: 2.503

3.  Hypofractionated accelerated radiotherapy in T1-3 N0 cancer of the larynx: A prospective cohort study with historical controls.

Authors:  Zbigniew Szutkowski; Andrzej Kawecki; Andrzej Jarząbski; Zofia Laskus; Romuald Krajewski; Wojciech Michalski; Paweł Kukołowicz
Journal:  Rep Pract Oncol Radiother       Date:  2016-09-20

4.  Radiotherapy for elderly patients and cetuximab, a monocentric study.

Authors:  Alexander T Falk; Christophe Hébert; Antoine Tran; Marie-Eve Chand; Axel Leysalle; Juliette Thariat; Olivier Dassonville; Gilles Poissonnet; Alexandre Bozec; Esma Saada; Fréderic Peyrade; Karen Benezery
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-10-11       Impact factor: 2.503

5.  The experience of nutritional care according to patients with head and neck cancer involved with a combined dietitian, specialist nurse and speech pathologist clinic in a regional Australia: a qualitative longitudinal study.

Authors:  Emily Hazzard; Jennifer Haughton; Janaye Fish; Marianna Milosavljevic; Vhari Dickson; Jessica Boehm; Karen Walton; Bruce Ashford
Journal:  Support Care Cancer       Date:  2021-01-07       Impact factor: 3.603

Review 6.  Management of interruptions in radiotherapy treatments: Adaptive implementation in high workload sites.

Authors:  Gustavo Pozo; Maria Angeles Pérez-Escutia; Ana Ruíz; Alejandro Ferrando; Ana Milanés; Eduardo Cabello; Raul Díaz; Alejandro Prado; Jose Fermin Pérez-Regadera
Journal:  Rep Pract Oncol Radiother       Date:  2019-02-26

7.  Prolonged Overall Treatment Time and Lack of Skin Rash Negatively Impact Overall Survival in Locally Advanced Head and Neck Cancer Patients Treated with Radiotherapy and Concomitant Cetuximab.

Authors:  Julien Roman; Gurvan Dissaux; Maelenn Gouillou; Yves Gobel; Gael Potard; Jean-Christophe Leclere; Virginie Conan-Charlet; Dorothy Gujral; Ronan Abgral; Briac Guibourg; Olivier Pradier; Ulrike Schick
Journal:  Target Oncol       Date:  2017-08       Impact factor: 4.493

8.  Effectiveness of tapentadol prolonged release for the management of painful mucositis in head and neck cancers during intensity modulated radiation therapy.

Authors:  Mazzola Rosario; Ricchetti Francesco; Fersino Sergio; Giaj Levra Niccolò; Fiorentino Alba; Nicodemo Maurizio; Albanese Sergio; Gori Stefania; Alongi Filippo
Journal:  Support Care Cancer       Date:  2016-07-22       Impact factor: 3.603

9.  Characteristic miRNA expression signature and random forest survival analysis identify potential cancer-driving miRNAs in a broad range of head and neck squamous cell carcinoma subtypes.

Authors:  Yury O Nunez Lopez; Berta Victoria; Pawel Golusinski; Wojciech Golusinski; Michal M Masternak
Journal:  Rep Pract Oncol Radiother       Date:  2017-11-20

10.  Impact of radiotherapy duration on overall survival in squamous cell carcinoma of the anus.

Authors:  Shahil Mehta; Stephen J Ramey; Deukwoo Kwon; Benjamin J Rich; Awad A Ahmed; Aaron Wolfson; Raphael Yechieli; Lorraine Portelance; Eric A Mellon
Journal:  J Gastrointest Oncol       Date:  2020-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.